Cryoport, Inc. (CYRX): M&A transaction — Cryoport completes CRYOPDP divestiture to DHL for ~$200M in cash; launches strategic partnership

Cryoport, Inc.

Total cash consideration of ~$200M: $133M purchase price plus repayment of $77.2M in intercompany loans.
Strategic partnership with DHL Group to collaborate on life sciences supply chain, expanding APAC and EMEA reach.
Pro forma net loss from continuing ops improves: Q1 2025 loss $7.3M vs. $9.0M reported; FY2024 loss $104.5M vs. $114.8M.
Company says deal provides capital to focus on advancing Life Science Services platform and Regenerative Medicine market.
Divested entity represented $71.6M revenue in FY2024; proceeds bolster cash to $246.3M pro forma as of March 31, 2025.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Cryoport, Inc. completed a disposition involving designated affiliates of DHL Supply Chain International Holding B.V. for cash payments of approximately $200 million to Cryoport (closed 2025-06-11).

Action: disposition
Counterparty: designated affiliates of DHL Supply Chain International Holding B.V.
Consideration: cash payments of approximately $200 million to Cryoport
Closing: 2025-06-11

Exact text from the filing

specialty courier business, CRYOPDP, to DHL Group ( “ DHL ” ), one of the world ’ s leading logistics providers, in a transaction that includes cash payments of approximately $200 million to Cryoport. Concurrently, Cryoport and DHL have established a strategic partnership aimed at enhancing their respective supply chain service offerings for the global life

View on SEC.gov

Browse all m&a transactions →

Cryoport, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-008613

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.